ENVB (Enveric Biosciences, Inc. Common Stock) Stock Analysis - Politician Trades

Enveric Biosciences, Inc. Common Stock (ENVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ENVB trades at $2.19 with a market cap of $4.27M and a P/E ratio of -0.16. ENVB moved +6.16% today. Year to date, ENVB is -45.41%; over the trailing twelve months it is -86.42%. Its 52-week range spans $1.71 to $99.90. Rallies surfaces ENVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ENVB stock?

Rallies tracks politician and congressional stock disclosures for ENVB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

ENVB Key Metrics

Key financial metrics for ENVB
MetricValue
Price$2.19
Market Cap$4.27M
P/E Ratio-0.16
EPS$-13.36
Dividend Yield0.00%
52-Week High$99.90
52-Week Low$1.71
Volume773
Avg Volume0
Revenue (TTM)$-411
Net Income$-8.22M
Gross Margin0.00%

Latest ENVB News

Recent ENVB Insider Trades

  • PASQUALONE FRANK bought 1.00K (~$2.14K) on Sep 15, 2023.

ENVB Analyst Consensus

ENVB analyst coverage data. Average price target: $0.00.

Common questions about ENVB

Which politicians traded ENVB stock?
Rallies tracks politician and congressional stock disclosures for ENVB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ENVB?
Yes. Rallies tracks politician and congressional stock disclosures for ENVB, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ENVB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ENVB. It does not provide personalized investment advice.
ENVB

ENVB